GenBank submission: novel NDM-42 variant identified in Klebsiella pneumoniae isolate from hospital outbreak in Mumbai, India. Confers resistance to all tested carbapenems.
Public note
For situational awareness and research transparency. Not medical advice.
Surveillance of emerging AMR phenotypes, carbapenem-resistant Enterobacterales spread, and novel resistance gene dissemination across healthcare settings.
Open assessments
Tracked assessments currently open in this scope.
Evidence items
Source-attributed evidence available to this scope.
Source feeds
Configured sources contributing data to this investigation.
Last activity
Most recent scope activity captured in the system.
Evidence quality mix
01
The current analyst view of this scope, at increasing levels of depth.
Steady state. Monitoring carbapenem resistance spread.
Global AMR surveillance data from GLASS and national reference labs shows continued spread of carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii. Novel NDM variants have been reported in South Asia. The system tracks resistance gene dissemination across borders via genomic surveillance.
02
Open assessments being tracked inside this scope, ordered for fast review.
03
The most recent source-attributed evidence flowing into this investigation.
GenBank submission: novel NDM-42 variant identified in Klebsiella pneumoniae isolate from hospital outbreak in Mumbai, India. Confers resistance to all tested carbapenems.